SYCE3 Activators are a set of compounds that indirectly heighten the functional activity of SYCE3 by modulating various cellular signaling mechanisms. Forskolin, IBMX, Rolipram, Anagrelide, Amrinone, Milrinone, and Cilostamide work predominately through the inhibition of different phosphodiesterases, leading to an accumulation of intracellular cAMP. This surge in cAMP activates PKA, which is known to phosphorylate proteins that may include components of the synaptonemal complex or its regulatory factors, thereby enhancing the function of SYCE3 in facilitating chromosomal pairing and recombination during meiosis. Meanwhile, compounds like Sildenafil, Zaprinast, and L-Arginine focus on elevating cGMP levels, which activates PKG. The activation of PKG is posited to stabilize the synaptonemal complex structure, a process crucial for the accurate segregation of chromosomes, where SYCE3 plays a key role.
SYCE3 Activators comprise a spectrum of chemical compounds that facilitate the enhancement of the SYCE3 protein's function in meiotic chromosomal pairing and recombination. The primary mode of activation for these compounds involves the modulation of intracellular levels of cAMP or cGMP, which are pivotal second messengers in cellular signal transduction pathways. Forskolin, IBMX, Rolipram, Anagrelide, Amrinone, Milrinone, and Cilostamide function by inhibiting various phosphodiesterases, thus preventing the breakdown of cAMP. This results in sustained PKA activation, which is known to phosphorylate cellular substrates that could include components crucial to the formation of the synaptonemal complex, thereby potentiating SYCE3's role in meiosis. Moreover, Sildenafil and Zaprinast, by inhibiting phosphodiesterase 5, augment cGMP levels, which activate PKG.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels and activating PKA. PKA activation can indirectly enhance SYCE3 function in meiotic chromosomal pairing and recombination. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, which elevates cAMP in the cytoplasm, thereby activating PKA. PKA can enhance SYCE3's activity by phosphorylation, affecting synapsis in meiosis. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5, increasing cGMP concentrations, which activates PKG. PKG activation may enhance the function of SYCE3 in the assembly or maintenance of the synaptonemal complex. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
L-Arginine is a substrate for nitric oxide synthase, which increases nitric oxide levels, subsequently raising cGMP levels and activating PKG. PKG then could promote the activity of SYCE3 in synaptonemal complex organization. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. Activated PKA may enhance SYCE3-mediated synapsis by phosphorylating proteins involved in synaptonemal complex formation. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Br-cGMP is a cGMP analog that activates PKG. PKG activation may support the function of SYCE3 in the synaptonemal complex structure and meiotic chromosomal pairing. | ||||||
Amrinone | 60719-84-8 | sc-207288 | 1 g | $193.00 | ||
Amrinone is a phosphodiesterase 3 inhibitor which results in elevated cAMP and activation of PKA. PKA may then enhance SYCE3's role in synaptonemal complex formation and function. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone selectively inhibits phosphodiesterase 3, increasing cAMP levels and activating PKA. PKA could promote SYCE3 activity in meiotic chromosomal synapsis and recombination processes. | ||||||